Total Funding
33
66
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
217246
RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research. near Philadelphia
Anthony Ford-Hutchinson: Chief Scientific Officer- Nigel Webb: President and Chief Executive Officer
About the Company
RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research near Philadelphia.
The company is developing novel therapies for the treatment of serious rare diseases, including mitochondrial disease and certain cancers. RiboNova's drug discovery platform is targeting transfer RNA molecules.
